Zirgan FDA Approval History
FDA Approved: Yes (First approved September 15, 2009)
Brand name: Zirgan
Generic name: ganciclovir
Dosage form: Ophthalmic Gel
Company: Sirion Therapeutics, Inc.
Treatment for: Keratitis
Zirgan (ganciclovir ophthalmic gel) is a topical ophthalmic antiviral preparation for the treatment of acute herpetic keratitis (dendritic ulcers).
Development Timeline for Zirgan
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.